All cancer research studies involving diagnosis, treatment, prevention and control that have not received traditional peer review for scientific merit must be submitted to the Protocol Review Committee (PRC) for review and approval. The MUSC Institutional Review Board (IRB) requires the PRC approval letter to accompany the initial submission therefore PRC review must occur before a study can be submitted to the IRB. Contact Information
Hollings Cancer Center
Protocol Review & Monitoring System
86 Jonathan Lucas St.
Suite 373
P.O. Box MSC 955
Charleston, SC 29425 | Neal Christiansen, MD, Chair-PRCI
Phone: 843-792-7581
E-Mail: hccprms@musc.edu Nester Esnaola, MD, Chair-PRCI Phone: 843-876-4420
E-Mail: hccprms@musc.edu | Philip Hall, PharmD, Chair-PRCII Phone: 843-792-8970
E-Mail: hccprms@musc.edu James Ravenel, MD, Chair-PRCII
Phone: 843-792-4363
E-Mail: hccprms@musc.edu | Brigette White, Administrator
Phone: 843-792-6231
E-Mail: hccprms@musc.edu | Pat Kelly, Administrative Coordinator
Phone: 843-792-9409
E-Mail: hccprms@musc.edu |
Protocol Review Committee Meeting Dates  2009-2010 Meeting Dates Protocol Review Committee Policies (policies currently under revision)
(Note: Several of the documents on this page require  Adobe@ Acrobat Reader)
Protocol Review Forms
PRC Submission Packet Checklist* Protocol Review Committee Submission Form * Protocol Review Committee Amendment Submission Form * Monthly Accrual Reporting Form* MUSC IRB Guidline for Review of Oncology Trials *Requires Microsoft Word For Members Only PRC Data Repository |
